Skip to content

Evaluation of the Effect of Adding Dexamethasone to 2% Lidocaine

Comparative Evaluation of Adding Dexamethasone to 2% Lidocaine (With and Without Epinephrine) on the Anesthetic Success Rate of Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05361291
Enrollment
124
Registered
2022-05-04
Start date
2020-02-01
Completion date
2021-08-25
Last updated
2022-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulpitis - Irreversible

Brief summary

This randomized, double-blind clinical trial aimed at the evaluation of the effect of adding dexamethasone to 2% lidocaine, given as inferior alveolar nerve block in the endodontic management of symptomatic irreversible pulpitis. One hundred and twenty four patients received one of the three IANB injections before the endodontic treatment: 2% lidocaine with 1:80 000 epinephrine; 2% lidocaine with 1:80 000 epinephrine mixed with 2mg dexamethasone; and plain 2% lidocaine mixed with 2mg dexamethasone. The anesthetia was considered successful if the patients experienced no pain or faint/weak/mild pain during root canal access preparation and instrumentation (HP VAS score \<55 mm). The effect of intraligamentary injections on maximum heart rates was also recorded.

Interventions

DRUGLidocaine Hydrochloride

Inferior alveolar nerve block

Sponsors

Jamia Millia Islamia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
Yes

Inclusion criteria

* absence of any periapical radiolucency on radiographs, except for a widened periodontal ligament * active pain in a mandibular molar * prolonged response to cold testing with an ice stick and an electric pulp tester * vital coronal pulp on access opening and ability to understand the use of pain scales

Exclusion criteria

* a history of known or suspected drug abuse * history of active peptic ulcer within the preceding 12 months * history of bleeding problems or anticoagulant use within the last month * known allergy, sensitivity, or contraindications to any opioid or nonopioid analgesic including aspirin or NSAIDs * patients who had taken NSAIDs within 12 h before administration of the study drugs * patients who were pregnant or breast-feeding

Design outcomes

Primary

MeasureTime frameDescription
Anesthtic success15 minutes after the inferior alveolar nerve blockPain during the endodontic treatment was assessed using a visual analog scale (Heft-Parker VAS). Success was defined as no or mild pain (pain score≤54mm on Hp VAS) during access preparation and root canal instrumentation.

Secondary

MeasureTime frameDescription
Heart RateAfter 1 minutes of initial injectionThe effect of injections on maximum heart rates was recorded.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026